Author

Jonathan B. Hauptman

Observed names: Hauptman, J, Hauptman, Jonathan, J B Hauptman, J Hauptman, J. Hauptman, J.B. Hauptman, Jonathan Hauptman, Jonathan Hauptman Md

Observed institutions: F. Hoffmann-La Roche AG, Scripps Health, St. Luke's-Roosevelt Hospital Center, United States Department of Veterans Affairs, Harvard University, Medical University of South Carolina, American Medical Association, Cornell University, Veterans Health Administration, Lexington VA Health Care System, East Orange VA Medical Center, Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Columbia University

OpenAlex ID: A5110505439

XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study

2004 · Jarl S. Torgerson, Jonathan Hauptman, et al. · Diabetes Care · 1,915

Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat

1999 · Michael H. Davidson, Jonathan Hauptman, et al. · JAMA · 947

Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans

2013 · Brian Finan, Tao Ma, et al. · Science Translational Medicine · 696

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

1998 · Priscilla A Hollander, Steven C Elbein, et al. · Diabetes Care · 654

Effect of Orlistat on Weight and Body Composition in Obese Adolescents

2005 · Jean-Pierre Chanoine, Sarah Hampl, et al. · JAMA · 624

Orlistat in the Long-term Treatment of Obesity in Primary Care Settings

2000 · J. Hauptman · Archives of Family Medicine · 367

Effects of Weight Loss With Orlistat on Glucose Tolerance and Progression to Type 2 Diabetes in Obese Adults

2000 · Steven B. Heymsfield, Karen R. Segal, et al. · Archives of Internal Medicine · 358

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study

1999 · James O Hill, Jonathan Hauptman, et al. · American Journal of Clinical Nutrition · 287

PDF

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

1994 · J Zhi, A T Melia, et al. · Clinical Pharmacology & Therapeutics · 278

Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X

2001 · Gerald Reaven, Karen Segal, et al. · The American Journal of Cardiology · 111

35th Annual Meeting of the European Association for the Study of Diabetes

1999 · A. Melander, J. Olsson, et al. · Diabetologia · 86

Long‐Term Systemic Exposure of Orlistat, a Lipase Inhibitor, and Its Metabolites in Obese Patients

1999 · Jianguo Zhi, Thomas E. Mulligan, et al. · The Journal of Clinical Pharmacology · 83

Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss

2009 · S. Jacob, M. Rabbia, et al. · Diabetes Obesity and Metabolism · 72

40th EASD Annual Meeting of the European Association for the Study of Diabetes

2004 · M. Veitenhansl, K. Stegner, et al. · Diabetologia · 66

Obesity: Low-Dose Orlistat Effects on Body Weight of Mildly to Moderately Overweight Individuals: A 16 Week, Double-Blind, Placebo-Controlled Trial

2006 · James W Anderson, Susan M Schwartz, et al. · Annals of Pharmacotherapy · 51

Orlistat: Selective Inhibition of Caloric Absorption Can Affect Long-Term Body Weight

2000 · Jonathan Hauptman · Endocrine · 38

Pheochromocytoma Resistant to a-Adrenergic Blockade

1983 · Jonathan B. Hauptman · Archives of Internal Medicine · 29

Effect of Orlistat on Fecal Fat, Fecal Biliary Acids, and Colonic Cell Proliferation in Obese Subjects

2007 · Dennis J. Ahnen, Roberto Guerciolini, et al. · Clinical Gastroenterology and Hepatology · 23

PDF

Effect of Orlistat on Weight and Body Composition in Obese Adolescents. A Randomized Controlled Trial

2005 · J.P. Chanoine, S. Hampl, et al. · ACC Current Journal Review · 19

Prospective comparison of four sampling methods (cystocentesis, bladder mucosal swab, bladder mucosal biopsy, and urolith culture) to identify urinary tract infections in dogs with urolithiasis

1998 · AJ Hamaide, SA Martinez, et al. · Journal of the American Animal Hospital Association · 19

Adrenergic blockade in pheochromocytoma.

1983 · R S Modlinger, N H Ertel, et al. · PubMed · 11

Orlistat in the Long-term Treatment of Obesity in Primary Care Settings.

2001 · J Hauptman, C Lucas, et al. · Journal of Cardiopulmonary Rehabilitation · 1

Effect of weight loss with orlistat on cardiovascular disease risk prediction in type 2 diabetes

2000 · Karen R Segal, Charles Lucas, et al. · Diabetes Research and Clinical Practice · 1

Xenical 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss

2011 · S Jacob, M Rabbia, et al. · Obesity and metabolism

PDF

Ксеникал 120 мг улучшает контроль гликемии у пациентов с сахарным диабетом 2 типа с или без сопутствующего снижения массы тела

2011 · Stephan Jacob, Michael Rabbia, et al. · CyberLeninK (CyberLeninka)

Works count: 32

Citation count: 6,743

H-index: 19

I10-index: 21